Apex Healthcare Berhad (KLSE:AHEALTH)
Malaysia · Delayed Price · Currency is MYR 2.610
0.00 (0.00%)
Inactive · Last trade price on Jan 12, 2026
Apex Healthcare Berhad Cash Flow Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 65.46 | 76.54 | 397.99 | 100.97 | 59.42 | 56.02 |
Depreciation & Amortization | 22.52 | 20.99 | 17.59 | 16.15 | 15.97 | 16.14 |
Other Amortization | 0.78 | 0.78 | 0.48 | 0.31 | 0.37 | 0.31 |
Loss (Gain) From Sale of Assets | -0.05 | -0.2 | -0.28 | -0.69 | -0.18 | -0.18 |
Asset Writedown & Restructuring Costs | 0.21 | 0.2 | 0 | 0 | 0.07 | 0.02 |
Loss (Gain) on Equity Investments | 14.42 | 9.78 | -336.4 | -29.57 | -7.1 | -8.66 |
Stock-Based Compensation | 0.81 | 0.88 | 0.75 | 0.64 | 0.67 | 0.72 |
Provision & Write-off of Bad Debts | 0.06 | 0.01 | 0.66 | 0.92 | -0.04 | 0.86 |
Other Operating Activities | -1.19 | -5.99 | -1.04 | 0.93 | 2.47 | -0.09 |
Change in Accounts Receivable | -18.95 | 1.71 | -13.02 | -19.21 | -30.59 | 25.13 |
Change in Inventory | 5.43 | -5.17 | -17.12 | -15.6 | -4.77 | -6.15 |
Change in Accounts Payable | 1.75 | -30.53 | 15.58 | 17.22 | 25.54 | -2.4 |
Change in Other Net Operating Assets | - | - | - | - | - | 3.77 |
Operating Cash Flow | 91.25 | 69 | 65.19 | 72.07 | 61.82 | 85.49 |
Operating Cash Flow Growth | 76.98% | 5.84% | -9.54% | 16.59% | -27.69% | 25.16% |
Capital Expenditures | 28.92 | -27.97 | -25.93 | -30.32 | -10.97 | -15.83 |
Sale of Property, Plant & Equipment | 0.11 | 0.32 | 0.35 | 0.78 | 0.18 | 0.29 |
Sale (Purchase) of Intangibles | -3 | -3 | -2.07 | -1.61 | -1.18 | -0.03 |
Sale (Purchase) of Real Estate | - | - | -0.23 | -2.28 | -0.91 | - |
Investment in Securities | 0.5 | 0.5 | -4.83 | - | - | - |
Other Investing Activities | 25.18 | 8.65 | 231.17 | 81.52 | -1.94 | -35.61 |
Investing Cash Flow | 51.7 | -21.5 | 198.45 | 48.1 | -14.81 | -51.17 |
Long-Term Debt Repaid | - | -8.54 | -6.69 | -6.64 | -6.94 | -4.13 |
Net Debt Issued (Repaid) | -59.2 | -8.54 | -6.69 | -6.64 | -6.94 | -4.13 |
Issuance of Common Stock | 2.26 | 2.92 | 2.62 | 2.11 | 1.59 | 3.57 |
Common Dividends Paid | -64.85 | -61.2 | -34.71 | -28.64 | -25.22 | -17.54 |
Other Financing Activities | -2.07 | -1.4 | -0.56 | -0.84 | -0.6 | -1.07 |
Financing Cash Flow | -145.5 | -212.16 | -48.91 | -62.63 | -31.17 | -19.17 |
Foreign Exchange Rate Adjustments | -0.82 | -3.45 | 1.07 | 3.11 | 1.39 | -0.01 |
Net Cash Flow | -3.37 | -168.1 | 215.81 | 60.65 | 17.23 | 15.14 |
Free Cash Flow | 120.17 | 41.03 | 39.26 | 41.76 | 50.85 | 69.66 |
Free Cash Flow Growth | - | 4.52% | -5.97% | -17.88% | -27.00% | 29.40% |
Free Cash Flow Margin | 12.39% | 4.27% | 4.19% | 4.76% | 6.60% | 9.97% |
Free Cash Flow Per Share | 0.17 | 0.06 | 0.06 | 0.06 | 0.07 | 0.10 |
Cash Interest Paid | 2.07 | 1.4 | 0.56 | 0.76 | 0.53 | 0.75 |
Cash Income Tax Paid | 25 | 24.83 | 21.14 | 17.65 | 13.97 | 14.36 |
Levered Free Cash Flow | 96.51 | 20.15 | 30.46 | 24.45 | 39.22 | 59.31 |
Unlevered Free Cash Flow | 97.78 | 21.03 | 30.81 | 24.93 | 39.76 | 60.02 |
Change in Working Capital | -11.77 | -33.99 | -14.56 | -17.6 | -9.82 | 20.35 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.